Parkview Health joins care providers nationwide in improving diabetes care for 1 million patients

FORT WAYNE, IND. – JAN. 30, 2020 – A partnership with the American Medical Group Association (AMGA), paired with a clinically integrated approach, is changing the way Parkview Health delivers diabetes care.

Parkview has utilized data and implemented best practices identified by AMGA to improve the quality of diabetes care delivered to patients. As part of AMGA’s Together 2 Goal® campaign, Parkview has joined providers across the country to share data on a variety of measures, including blood sugar control, blood pressure control, lipid management and testing for kidney disease. The information allows providers to compare practices and outcomes among similar patient populations.

“Partnering with AMGA and their Together 2 Goal campaign has revealed much to us about how we care for those with diabetes,” said Greg Johnson, DO, chief clinical integration officer, Parkview Health. “They packaged the data in a way that was easily understood and actionable, and it allowed us to see how we compare to our peers across the country. We will continue to leverage this data to be better stewards of our healthcare resources and provide patient-centered care at the right time, by the right resource.”

To date, more than 150 medical groups and health systems have joined the campaign, resulting in more people with safer ranges for critical diabetes measures, like blood sugar and blood pressure. In January, AMGA announced its campaign had exceeded its goal of improving diabetes for 1 million patients nationwide.

In addition to using data and best practices from AMGA, Parkview has implemented a clinically integrated approach to diabetes management, facilitating care across medical conditions, providers, locations and time. Dedicated care coordinators work with patients to tailor a personalized healthcare plan that meets their individual goals and walk alongside them throughout the journey, connecting them to nurses, social workers, pharmacists and other experts to get the resources they need.  

“A clinically integrated, population-based approach results in improved quality of care and a better patient experience, among other benefits,” said Emily Schroeder, MD, medical director for Parkview’s Diabetes Care Strategy team, which was created in 2019 to facilitate the innovative approach to care across Parkview Health. 

Chad Shirar, director of Diabetes Care Strategy, Parkview Health, emphasized the importance of combatting one of the nation’s most pressing chronic conditions.

“Diabetes is difficult to manage, for both patients and clinicians,” Shirar said. “AMGA’s data and platform has shown us how to best serve our community. We look forward to continued collaboration, particularly with the Together 2 Goal campaign, to sustain and improve the diabetes care our community deserves.”

Though Together 2 Goal has exceeded its original goal, the initiative will continue to run through March 2021. Parkview and other participants will use this additional time to refine and hardwire care process improvements.


About AMGA

AMGA is a trade association leading the transformation of health care in America. Representing multispecialty medical groups and integrated systems of care, it advocates, educates, innovates and empowers members to deliver the next level of high performance health. AMGA is the national voice promoting awareness of members’ recognized excellence in the delivery of coordinated, high-quality, high-value care. More than 175,000 physicians practice in AMGA’s member organizations, delivering care to one in three Americans.

About the Together 2 Goal® Campaign

AMGA Foundation, the philanthropic arm of AMGA, launched Together 2 Goal, a national campaign to fight the challenge of Type 2 diabetes on March 12, 2016. Together 2 Goal includes more than 150 medical groups, health systems, nonprofit partners, and corporate collaborators such as the American Association of Diabetes Educators, American Diabetes Association, Geisinger, Henry Ford Health System, The Janssen Pharmaceuticals Companies of Johnson & Johnson, Intermountain Healthcare, and Ochsner Health System. The goal of the five-year campaign is to improve care for 1 million people with Type 2 diabetes by 2021.